S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
S&P 500   2,626.65 (+3.35%)
DOW   22,327.48 (+3.19%)
QQQ   192.04 (+3.64%)
AAPL   254.81 (+2.85%)
FB   165.95 (+5.84%)
MSFT   160.23 (+7.03%)
GOOGL   1,146.31 (+3.25%)
AMZN   1,963.95 (+3.36%)
CGC   14.46 (-0.89%)
NVDA   265.59 (+5.09%)
BABA   191.27 (+1.42%)
MU   44.52 (+2.39%)
GE   7.89 (+3.54%)
TSLA   502.13 (-2.38%)
AMD   47.86 (+2.75%)
T   30.23 (+1.31%)
ACB   0.89 (-13.63%)
F   5.03 (-3.08%)
NFLX   370.96 (+3.88%)
BAC   22.04 (+2.04%)
GILD   75.93 (+4.23%)
PRI   90.71 (+0.83%)
DIS   99.80 (+3.53%)
Log in

NASDAQ:MSON - Misonix Stock Price, Forecast & News

$9.64
+0.23 (+2.44 %)
(As of 03/30/2020 04:00 PM ET)
Today's Range
$9.34
Now: $9.64
$10.25
50-Day Range
$7.01
MA: $13.17
$17.78
52-Week Range
$6.71
Now: $9.64
$27.54
Volume50,339 shs
Average Volume104,045 shs
Market Capitalization$167.35 million
P/E RatioN/A
Dividend YieldN/A
Beta0.7
Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York.
Read More
Misonix logo

Industry, Sector and Symbol

Industry Laboratory apparatus & furniture
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:MSON
CUSIPN/A
Phone631-694-9555

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$38.85 million
Book Value$2.25 per share

Profitability

Net Income$-7,390,000.00

Miscellaneous

Employees118
Market Cap$167.35 million
Next Earnings Date5/13/2020 (Estimated)
OptionableNot Optionable

Receive MSON News and Ratings via Email

Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter.


Misonix (NASDAQ:MSON) Frequently Asked Questions

How has Misonix's stock been impacted by COVID-19 (Coronavirus)?

Misonix's stock was trading at $10.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MSON shares have decreased by 9.7% and is now trading at $9.64. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Misonix?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Misonix.

When is Misonix's next earnings date?

Misonix is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Misonix.

How were Misonix's earnings last quarter?

Misonix, Inc. (NASDAQ:MSON) announced its quarterly earnings results on Wednesday, February, 5th. The medical equipment provider reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.08. The medical equipment provider earned $19.72 million during the quarter. Misonix had a negative return on equity of 7.80% and a negative net margin of 14.40%. View Misonix's earnings history.

What guidance has Misonix issued on next quarter's earnings?

Misonix updated its FY 2020 After-Hours earnings guidance on Wednesday, February, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $46.618 million, compared to the consensus revenue estimate of $73.25 million.

What price target have analysts set for MSON?

2 equities research analysts have issued 12-month price targets for Misonix's stock. Their forecasts range from $27.00 to $30.00. On average, they anticipate Misonix's stock price to reach $28.50 in the next year. This suggests a possible upside of 195.6% from the stock's current price. View analysts' price targets for Misonix.

Has Misonix been receiving favorable news coverage?

News articles about MSON stock have trended negative on Monday, InfoTrie Sentiment Analysis reports. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Misonix earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutMisonix.

Who are some of Misonix's key competitors?

What other stocks do shareholders of Misonix own?

Who are Misonix's key executives?

Misonix's management team includes the following people:
  • Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 49)
  • Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 63)
  • Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 52)
  • Ms. Sharon W. Klugewicz, Chief Operating Officer (Age 51)
  • Mr. John J. Salerno, VP of Quality and Regulatory Affairs & Chief Compliance Officer (Age 64)

What is Misonix's stock symbol?

Misonix trades on the NASDAQ under the ticker symbol "MSON."

Who are Misonix's major shareholders?

Misonix's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Parkman Healthcare Partners LLC (1.22%), Renaissance Technologies LLC (0.82%), Geode Capital Management LLC (0.81%), State Street Corp (0.86%), Essex Investment Management Co. LLC (0.56%) and Ingalls & Snyder LLC (0.31%). Company insiders that own Misonix stock include Christopher H Wright, Joseph J Brennan, Joseph P Dwyer, Sharon W Klugewicz and Stavros G Vizirgianakis. View institutional ownership trends for Misonix.

Which institutional investors are selling Misonix stock?

MSON stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Martingale Asset Management L P, Acadian Asset Management LLC, Bessemer Group Inc., and Ingalls & Snyder LLC. View insider buying and selling activity for Misonix.

Which institutional investors are buying Misonix stock?

MSON stock was bought by a variety of institutional investors in the last quarter, including Parkman Healthcare Partners LLC, State Street Corp, Geode Capital Management LLC, Bank of Montreal Can, Tiedemann Advisors LLC, DAVENPORT & Co LLC, Bank of America Corp DE, and Charles Schwab Investment Management Inc.. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Sharon W Klugewicz, and Stavros G Vizirgianakis. View insider buying and selling activity for Misonix.

How do I buy shares of Misonix?

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Misonix's stock price today?

One share of MSON stock can currently be purchased for approximately $9.64.

How big of a company is Misonix?

Misonix has a market capitalization of $167.35 million and generates $38.85 million in revenue each year. Misonix employs 118 workers across the globe. View additional information about Misonix.

What is Misonix's official website?

The official website for Misonix is http://www.misonix.com/.

How can I contact Misonix?

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.


MarketBeat Community Rating for Misonix (NASDAQ MSON)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  115 (Vote Outperform)
Underperform Votes:  137 (Vote Underperform)
Total Votes:  252
MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel